MedPath

The effect of zinc supplementation on CD4+ lymphocyte cell count in HIV patients in Iranian research center: a randomized double blind controlled trial

Early Phase 1
Conditions
HIV infection.
Unspecifidied immunodeficiency virus [hiv]disease
Registration Number
IRCT138904244380N1
Lead Sponsor
Vice Chancellor For Research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Inclusion Criteria: Age 18-60 years, Confirmed HIV-1 infection with western blot test, receiving HAART, CD4 between 200 and 350, signing informed consent Exclusion criteria: Pregnancy, any other supplementation than zinc, history of hypersensitivity to Zinc, unwilling to cooperate, any plan to leave Tehran during the next 9 months after beginning of the study, History of chronic kidney diseases

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath